Multiple sclerosis (MS) is a heterogenous autoimmune disease in which autoreactive
lymphocytes attack the myelin sheath of the central nervous system. B lymphocytes in the …

A rapidly expanding and clinically distinct group of CNS diseases are caused by pathogenic
autoantibodies that target neuroglial surface proteins. Despite immunotherapy, patients with …

High‐throughput sequencing of the DNA/RNA encoding antibody heavy‐ and light‐chains is
rapidly transforming the field of adaptive immunity. It can address key questions, including: (i…

Deep sequencing of B cell receptor (BCR) heavy chains from a cohort of 31 COVID-19
patients from the UK reveals a stereotypical naive immune response to SARS-CoV-2 which is …

The adaptive immune response selectively expands B- and T-cell clones following antigen
recognition by B- and T-cell receptors (BCR and TCR), respectively. Next-generation …

B lymphocyte development and selection are central to adaptive immunity and self-tolerance.
These processes require B cell receptor (BCR) signaling and occur in bone marrow, an …

B cells are important in immunity to both severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection and vaccination, but B cell receptor (BCR) repertoire development in …

Sequencing studies of diffuse large B cell lymphoma (DLBCL) have identified hundreds of
recurrently altered genes. However, it remains largely unknown whether and how these …

The strongest predictor of relapse in B-cell acute lymphoblastic leukemia (B-ALL) is the
level of persistence of tumor cells after initial therapy. The high mutation rate of the B-cell …

Background Deep-sequencing methods are rapidly developing in the field of B-cell receptor
(BCR) and T-cell receptor (TCR) diversity. These promise to revolutionise our …